Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 2/20 | 0.56 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.43 |
| ▸ | HTR6 | P50406 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 4/20 | 0.41 |
| ▸ | CNR1 | P21554 | 2/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.41 |
| ▸ | CDK4 | P11802 | 2/20 | 0.40 |
| ▸ | CCND1 | P24385 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | CYP24A1 | Q07973 | 1/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12542708 | 0.85 | HTR2C (0.58) | HTR2CPRMT5HTR6KMT2ASMN1; SMN2 | |
| SCHEMBL8223661 | 0.81 | HTR2C (0.51) | HTR2CPRMT5HTR6KMT2ASMN1; SMN2 | |
| SCHEMBL8226916 | 0.81 | HTR2C (0.51) | HTR2CPRMT5HTR6KMT2ASMN1; SMN2 | |
| SCHEMBL12543673 | 0.80 | HTR2C (0.60) | HTR2CPRMT5HTR6KMT2ASMN1; SMN2 | |
| SCHEMBL7958454 | 0.80 | HTR2C (0.60) | HTR2CPRMT5HTR6KMT2ASMN1; SMN2 | |
| SCHEMBL5841409 | 0.78 | CDK4 (0.44) | HTR2CKMT2ASMN1; SMN2CNR2CNR1 | |
| SCHEMBL7959260 | 0.78 | HTR2C (0.54) | HTR2CPRMT5HTR6KMT2ASMN1; SMN2 | |
| SCHEMBL13228252 | 0.78 | HTR2C (0.65) | HTR2CPRMT5HTR6KMT2ASMN1; SMN2 | |
| SCHEMBL23927902 | 0.78 | HTR2C (0.64) | HTR2CPRMT5HTR6ALDH1A1 | |
| SCHEMBL5794361 | 0.77 | P2RX7 (0.54) | HTR2CPRMT5HTR6CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230120881-A1 | BINUCLEAR GOLD(I) COMPOUNDS FOR PHOTOCATALYSIS APPLICATIONS | University of Hong Kong Versitech Limited (CN) | 2023-04-20 | — | — | US | disclosed |
| US-20230120881-A1 | BINUCLEAR GOLD(I) COMPOUNDS FOR PHOTOCATALYSIS APPLICATIONS | University of Hong Kong Versitech Limited (CN) | 2023-04-20 | — | — | US | disclosed |
| EP-4122940-A1 | BINUCLEAR GOLD(I) COMPOUNDS FOR PHOTOCATALYSIS APPLICATIONS | Versitech Limited (CN) | 2023-01-25 | — | — | EP | disclosed |
| EP-4122940-A1 | BINUCLEAR GOLD(I) COMPOUNDS FOR PHOTOCATALYSIS APPLICATIONS | Versitech Limited (CN) | 2023-01-25 | — | — | EP | disclosed |
| CN-115636840-A | Binuclear gold (I) compounds for photocatalytic applications | 港大科桥有限公司 | 2023-01-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230120881-A1 | BINUCLEAR GOLD(I) COMPOUNDS FOR PHOTOCATALYSIS APPLICATIONS | PPOX, AP3M1, AP2M1 | HTR2C 279/4885PRMT5 773/4885HTR6 1945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.